Andrew Zimmerman to Sulfoxides
This is a "connection" page, showing publications Andrew Zimmerman has written about Sulfoxides.
Connection Strength
0.481
-
Zimmerman AW, Singh K, Connors SL, Liu H, Panjwani AA, Lee LC, Diggins E, Foley A, Melnyk S, Singh IN, James SJ, Frye RE, Fahey JW. Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder. Mol Autism. 2021 05 25; 12(1):38.
Score: 0.189
-
Singh K, Zimmerman AW. Sulforaphane Treatment of Young Men with Autism Spectrum Disorder. CNS Neurol Disord Drug Targets. 2016; 15(5):597-601.
Score: 0.130
-
Singh K, Connors SL, Macklin EA, Smith KD, Fahey JW, Talalay P, Zimmerman AW. Sulforaphane treatment of autism spectrum disorder (ASD). Proc Natl Acad Sci U S A. 2014 Oct 28; 111(43):15550-5.
Score: 0.119
-
Liu H, Zimmerman AW, Singh K, Connors SL, Diggins E, Stephenson KK, Dinkova-Kostova AT, Fahey JW. Biomarker Exploration in Human Peripheral Blood Mononuclear Cells for Monitoring Sulforaphane Treatment Responses in Autism Spectrum Disorder. Sci Rep. 2020 04 02; 10(1):5822.
Score: 0.044